- Future Students
- Current Students
- Faculty & Staff
Filters: Author is Wu, Martin [Clear All Filters]
Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. 2003. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.. The Journal of infectious diseases. 187(12):1977-80.
Bermudez LE, Kolonoski P, Seitz LE, Petrofsky M, Reynolds R, Wu M, Young LS. 2004. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.. Antimicrobial agents and chemotherapy. 48(9):3556-8.
Danelishvili L, Wu M, Stang BV, Harriff M, Cirillo SLG, Cirillo S, Cirillo JD, Cirillo J, Bildfell RJ, Arbogast B et al.. 2007. Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection.. Proceedings of the National Academy of Sciences of the United States of America. 104(26):11038-43.
Harriff MJ, Danelishvili L, Wu M, Wilder C, McNamara M, Kent ML, Bermudez LE. 2009. Mycobacterium avium genes MAV_5138 and MAV_3679 are transcriptional regulators that play a role in invasion of epithelial cells, in part by their regulation of CipA, a putative surface protein interacting with host cell signaling pathways.. Journal of bacteriology. 191(4):1132-42.
Harriff MJ, Wu M, Kent ML, Bermudez LE. 2008. Species of environmental mycobacteria differ in their abilities to grow in human, mouse, and carp macrophages and with regard to the presence of mycobacterial virulence genes, as observed by DNA microarray hybridization.. Applied and environmental microbiology. 74(1):275-85.